Group One Trading, L.P. Hookipa Pharma Inc. Transaction History

Group One Trading, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $1.04 $24,544 - $43,264	41,600 Added 239.03%	59,004 $34,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.86 $14,565 - $29,824	-34,680 Reduced 66.58%	17,404 $14,000
Q3 2023 Nov 09, 2023	SELL	$0.58 - $0.91 $8,404 - $13,186	-14,491 Reduced 21.77%	52,084 $32,000
Q2 2023 Aug 09, 2023	BUY	$0.71 - $1.97 $18,371 - $50,973	25,875 Added 63.57%	66,575 $58,000
Q1 2023 May 12, 2023	SELL	$0.72 - $1.03 $3,399 - $4,863	-4,722 Reduced 10.4%	40,700 $30,000
Q4 2022 Feb 09, 2023	BUY	$0.73 - $14.6 $9,993 - $199,874	13,690 Added 43.14%	45,422 $36,000
Q3 2022 Nov 09, 2022	SELL	$1.27 - $15.0 $57,745 - $682,035	-45,469 Reduced 58.9%	31,732 $43,000
Q2 2022 Aug 11, 2022	BUY	$1.33 - $2.31 $38,566 - $66,983	28,997 Added 60.15%	77,201 $126,000
Q1 2022 May 12, 2022	BUY	$1.26 - $2.52 $55,776 - $111,552	44,267 Added 1124.38%	48,204 $110,000
Q4 2021 Feb 11, 2022	BUY	$2.33 - $5.94 $8,010 - $20,421	3,438 Added 688.98%	3,937 $9,000
Q3 2021 Nov 12, 2021	SELL	$5.89 - $9.35 $10,013 - $15,895	-1,700 Reduced 77.31%	499 $3,000
Q2 2021 Aug 10, 2021	BUY	$9.16 - $19.51 $20,142 - $42,902	2,199 New	2,199 $20,000

713K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $173M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.